|1.||Al-Hassnan, Zuhair N: 1 article (05/2012)|
|2.||Al-Muhaizea, Muhammad: 1 article (05/2012)|
|3.||Colak, Dilek: 1 article (05/2012)|
|4.||Kaya, Namik: 1 article (05/2012)|
|5.||Chedrawi, Aziza K: 1 article (05/2012)|
|6.||Tulba, Sahar: 1 article (05/2012)|
|7.||Al-Younes, Banan: 1 article (05/2012)|
|8.||Albakheet, Albandary: 1 article (05/2012)|
|9.||Vanhuse, Cherie: 1 article (07/2008)|
|10.||Newton, Kimberly P: 1 article (07/2008)|
01/01/2000 - "This study presents four cases of Farber's disease who all presented by hoarseness of voice, polyarthritis and subcutaneous nodules. "
05/01/2002 - "Farber's disease is a rare autosomal recessive disorder caused by a deficiency of acid ceramidase activity whose symptoms include hoarseness, subcutaneous nodules, and painful swollen and contracted joints. "
05/01/2012 - "Farber disease is a rare inherited lysosomal storage disorder caused by ceramidase deficiency that leads to accumulation of ceramide in various tissues. "
04/10/1998 - "The metabolic fate of radiolabelled ceramide produced by intralysosomal hydrolysis of LDL-associated [ceramide-3H]sphingomyelin or [stearoyl-1-(14)C]sulfatide was examined in fibroblasts from control individuals and a patient with inborn lysosomal ceramidase deficiency (Farber disease). "
12/01/1995 - "Neurodegenerative course in ceramidase deficiency (Farber disease) correlates with the residual lysosomal ceramide turnover in cultured living patient cells."
07/01/1987 - "Farber's disease (lysosomal acid ceramidase deficiency)."
08/01/2000 - "Bone marrow transplantation for infantile ceramidase deficiency (Farber disease)."
|4.||Lysosomal Storage Diseases (Lysosomal Storage Disease)
08/01/2000 - "Infantile ceramidase deficiency (Farber disease) is an uncommon, progressive lysosomal storage disease characterized by multiple ceramide-containing nodules (lipogranulomata) in the subcutaneous tissue and upper aerodigestive tract, painful periarticular swelling, psychomotor retardation, and varying degrees of ocular, pulmonary or hepatic involvement. "
09/01/1998 - "Fumonisins may serve as templates for therapeutic agents for treating diseases related to sphingolipid turnover (lysosomal storage disease), such as Farber's disease."
|1.||Bone Marrow Transplantation (Transplantation, Bone Marrow)